Moreover, after PMN isolation, we observed that PAD patients with autoimmunity displayed a higher expression of CD11b, CD11c, and CD16 on PMN compared to patients without autoimmune manifestations (p = 0.001, p = 0.001, and p < 0.001, respectively; Figure S2). This evidence concerns the gene ITGAX and peripheral arterial disease.